StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Moderna (MRNA) PT Lowered to $325 at Jefferies
November 5, 2021 8:24 AM
Jefferies analyst Michael Yee lowered the price target on Moderna (NASDAQ: MRNA) to $325.00 (from $375.00) while maintaining a Hold ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Moderna (MRNA) Requests to Expand Conditional Marketing Authorization for its COVID-19 Vaccine in the EU to Include Children Ages 6-11 Years
November 9, 2021 8:33 AM
Moderna (MRNA) Hits Low, Down 25% on Session
November 5, 2021 12:51 PM
Moderna (MRNA) Falls 5% Following Positive Pfizer COVID-19 Oral Antiviral Treatment Data
November 5, 2021 7:01 AM
Moderna (MRNA) PT Lowered to $404 at Barclays
November 5, 2021 4:51 AM
Moderna (MRNA) PT Lowered to $395 at Goldman Sachs
November 5, 2021 4:24 AM
Moderna (MRNA ) PT Lowered to $313 at Morgan Stanley
November 5, 2021 3:44 AM
